The EMA has endorsed Aquipta, an oral CGRP receptor antagonist, after it showed superior pain relief vs placebo in treating migraine attacks in adults.
Suffering from migraines? You are not alone, and it feels awful. Migraine is more than just a headache. According to the American Migraine Foundation, at least 39 million Americans live with migraines ...
Migraines are more than just bad headaches—they’re a complex neurological condition with a wide range of triggers, symptoms, and treatment options. From cutting-edge CGRP medications to lifestyle ...